Invention Grant
- Patent Title: Enzymatic method for preparation of UDP-GlcNAc
-
Application No.: US17755653Application Date: 2020-09-30
-
Publication No.: US11767546B2Publication Date: 2023-09-26
- Inventor: Reza Mahour , Thomas F. T. Rexer
- Applicant: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
- Applicant Address: DE Munich
- Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
- Current Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
- Current Assignee Address: DE Munich
- Agency: Knobbe Martens Olson & Bear LLP
- Priority: EP 207017 2019.11.05
- International Application: PCT/EP2020/077383 2020.09.30
- International Announcement: WO2021/089249A 2021.05.14
- Date entered country: 2022-05-04
- Main IPC: C12P19/30
- IPC: C12P19/30 ; C12N9/12 ; C12N9/10 ; C12N9/14 ; C12N11/08 ; C12N11/087 ; C12P19/18 ; C12P21/00

Abstract:
The present invention relates to an enzyme-catalyzed process for producing UDP-N-acetyl-α-D-glucosamine (UDP-GlcNAc) from low-cost substrates uridine monophosphate and N-acetyl-D glucosamine in a single reaction mixture with immobilized or preferably co-immobilized enzymes. Uridine may be used as starting material instead of uridine monophosphate as well. Further, the process may be adapted to produce GlcNAcylated molecules and biomolecules including saccharides, particularly human milk oligosaccharides (HMO), proteins, peptides, glycoproteins, particularly antibodies, or glycopeptides, and bioconjugates, particularly carbohydrate conjugate vaccines and antibody-drug conjugates.
Public/Granted literature
- US20220380820A1 ENZYMATIC METHOD FOR PREPARATION OF UDP-GLCNAC Public/Granted day:2022-12-01
Information query